Breast Invasive Carcinoma (TCGA, Cell 2015)

Summary

Breast Invasive Carcinoma (TCGA, Cell 2015) is a study catalogued by cBioPortal DataHub under the cancer-type code brca. EvidenceHelix groups it with breast studies and lists it in the TCGA (other releases) collection.

Study description

Whole-exome sequencing of 817 Breast Invasive Carcinoma tumor/normal pairs. The Cancer Genome Atlas (TCGA) Breast Invasive Carcinoma Project.

Text as published in the source's study metadata.

Citation & PubMed

TCGA, Cell 2015

Linked PubMed records: PMID 26451490

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

brca_tcga_pub2015

Short name

Breast (TCGA 2015)

Source cancer-type code

brca

Reference genome

not given

Source access groups

PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data. TCGA data are available under the Broad Institute GDAC TCGA Analysis Pipeline License; TCGA-derived records are preliminary or legacy releases.

Citations

TCGA, Cell 2015

• PubMed record 26451490 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Breast Invasive Carcinoma (TCGA, Nature 2012)

  Whole-exome sequencing (510 samples with matched normals), genomic DNA copy number arrays, DNA methylation, messenger RNA arrays, microRNA sequencing and reverse-phase protein arrays analysis on 825 primary breast can…

  BreastTCGA (other releases)Source code brcaPubMed 1

• Breast Cancer (HTAN, 2022)

  An omic and multidimensional spatial (OMS) atlas generated from four serial biopsies of an individual with metastatic breast cancer during 3.5 years of therapy. This resource links detailed, longitudinal clinical meta…

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)

  Targeted sequencing of 2509 primary breast tumors with 548 matched normals.

  BreastOther published and consortium studiesSource code brcaPubMed 3

• Breast Cancer (MSK, Clinical Cancer Res 2020)

  Whole-exome and MSK-IMPACT sequencing of 60 tumor/normal matched samples.

  BreastMSK studiesSource code brcaPubMed 1

• Breast Cancer (MSK, NPJ Breast Cancer 2019)

  Targeted Sequencing of buparlisib + letrozole and alpelisib + letrozole-treated metastatic ER+ unmatched breast tumors.

  BreastMSK studiesSource code brcaPubMed 1

• Breast Cancer (SMC 2018)

  Whole-exome sequencing of 187 primary tumors from a Korean breast cancer cohort (SMC).

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Breast Cancer Xenografts (British Columbia, Nature 2015)

  Whole genome/targeted sequencing to evaluate the clonal dynamics in 116 breast cancer patient xenografts.

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Breast Invasive Carcinoma (British Columbia, Nature 2012)

  Whole genome/exome sequencing analysis of 65 breast cancer samples

  BreastOther published and consortium studiesSource code brcaPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.